These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3290716)

  • 21. Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trials.
    Sørensen PS
    Neurol Sci; 2003 Oct; 24 Suppl 4():S227-30. PubMed ID: 14598048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
    Stuart WH
    Curr Med Res Opin; 2007 Jun; 23(6):1199-208. PubMed ID: 17559719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis.
    Trebst C; Reising A; Kielstein JT; Hafer C; Stangel M
    Blood Purif; 2009; 28(2):108-15. PubMed ID: 19521072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current therapy of multiple sclerosis].
    Vass K; Schmied M
    Wien Med Wochenschr; 1996; 146(19-20):514-9. PubMed ID: 9082651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Plasmapheresis in the treatment of neurologic disorders].
    Szobor A; Fornádi L; Vájlok M
    Orv Hetil; 1988 Jan; 129(3):119-23. PubMed ID: 3281091
    [No Abstract]   [Full Text] [Related]  

  • 26. [Plasmapheresis as a method of intensive care in neurology].
    Piradov MA
    Anesteziol Reanimatol; 1996; (2):92-4. PubMed ID: 8754188
    [No Abstract]   [Full Text] [Related]  

  • 27. Is multiple sclerosis an autoimmune disease?
    Gulcher JR; Vartanian T; Stefansson K
    Clin Neurosci; 1994; 2(3-4):246-52. PubMed ID: 7749894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmapheresis in myasthenia gravis.
    Dau PC
    Prog Clin Biol Res; 1982; 88():265-85. PubMed ID: 7100216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Which patients should be treated with plasma exchange? Indications for plasma exchange therapy].
    Cala S
    Lijec Vjesn; 1996; 118(11-12):286-90. PubMed ID: 9213718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Plasmapheresis and immunosuppressive drugs in the treatment of multiple sclerosis].
    Cendrowski W
    Neurol Neurochir Pol; 1984; 18(3):259-62. PubMed ID: 6390235
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasmapheresis in acute attacks of multiple sclerosis: the cons.
    Rostami AM
    J Clin Apher; 1991; 6(4):205-6. PubMed ID: 1816241
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current therapy of multiple sclerosis. Are there indications for plasmapheresis?].
    Schönbeck S; Hohlfeld R
    Nervenarzt; 1992 Feb; 63(2):116-9. PubMed ID: 1314334
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs.
    Khatri BO; McQuillen MP; Harrington GJ; Schmoll D; Hoffmann RG
    Neurology; 1985 Mar; 35(3):312-9. PubMed ID: 3974889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Review. The status of plasmapheresis and apheresis].
    Schmitt E; Klinkmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):291-309. PubMed ID: 2428704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppression and plasmapheresis in chronic progressive multiple sclerosis. Design of a clinical trial.
    Hauser SL; Dawson DM; Lehrich JR; Beal MF; Kevy SV; Weiner HL
    Arch Neurol; 1983 Oct; 40(11):687-90. PubMed ID: 6354151
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasmapheresis (plasma exchange) in neurologic disorders.
    Norris FH; Denys EH; Mielke CH
    Clin Neuropharmacol; 1982; 5(1):93-114. PubMed ID: 7046924
    [No Abstract]   [Full Text] [Related]  

  • 37. [Successful treatment with additional plasmapheresis for the exacerbation of acute neurological symptoms in a girl with multiple sclerosis].
    Mogami Y; Yamada K; Toribe Y; Yanagihara K; Mano T; Suzuki Y
    No To Hattatsu; 2011 Jan; 43(1):36-40. PubMed ID: 21400930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical applications of therapeutic apheresis.
    Balogun RA; Kaplan A; Ward DM; Okafor C; Burns TM; Torloni AS; Macik BG; Abdel-Rahman EM
    J Clin Apher; 2010; 25(5):250-64. PubMed ID: 20806279
    [No Abstract]   [Full Text] [Related]  

  • 39. Pathophysiological changes of inflammatory syndrome in multiple sclerosis after instituting therapeutic plasmapheresis.
    Vlaic S; Poalelungi V; Bălăeţ M; Purcărea VL; Bălăeţ C; Coculescu BI
    J Med Life; 2017; 10(1):50-53. PubMed ID: 28255377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmapheresis in chronic progressive multiple sclerosis: pro.
    McQuillen MP
    J Clin Apher; 1991; 6(4):207-10. PubMed ID: 1816242
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.